Julie Kerr-Conte (BSc, MSc, PhD) is Professor of Cell Biology/Cell Therapy at the University of Lille, France, where she works in the INSERM U1190 team on Translational Research for Diabetes. She completed a BSc from SUNY Albany, New York in 1986, her MSc from the University of Wisconsin, Madison in 1990 and her PhD from the Science and Technology University, Lille 1 in 1995.

She is responsible for research and clinical grade human islet isolation (French FDA [ANSM]-approved process) and Director of the core Biotherapies Platform since 2012 (French FDA-approved facility) Deputy Director, INSERM U1190 Translational Research for Diabetes. She is a recognised technical expert and a faculty member of NICE Networks of Islet Cell Transplantation in Europe. She is responsible for the manned Biotherapies Platform, authorised by the French FDA for auto- and allograft cell therapy of diabetes (230 islet allo/autotransplants).  She has published more than 200 articles in peer-reviewed journals.

Professor Kerr-Conte is a member of the EASD (since 1995), the International Pancreas and Islet Transplantation Association, International pancreas and Islet transplantation association (IPITA), and chair of the European Islet and Pancreas Transplantation Association affiliated with the European Society for Organ Transplantation.

Duality of interest: none declared

Date: Autumn 2023